|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 8.930 USD | +4.44% |
|
-5.40% | -14.95% |
| 08-18 | Immatics' Q2 Net Loss Narrows as Revenue Rises | MT |
| 08-18 | Earnings Flash (IMTX) Immatics Posts Q2 Revenue 9.1M Euros, vs. FactSet Est of 10.4M Euros | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||
Biotechnology | 34.76M | 173M | 54M | 156M | 48.27M | |||
Total Assets | 175M | 408M | 510M | 696M | 562M | |||
Interest Expense | -566K | -1.04M | -831K | -886K | -946K | |||
Income Tax Expense | - | 4.52M | - | 6.13M | -1.99M | |||
CAPEX | -5.66M | -6.22M | -30.8M | -16.27M | -6.56M | |||
EBT | -93.34M | 42.04M | -96.99M | 21.35M | -198M | |||
D&A | 5.15M | 6.81M | 7.1M | 12.15M | 12.37M | |||
Operating Income | -86.29M | 29.95M | -102M | -38.62M | -182M | |||
Net Income | -93.34M | 37.51M | -96.99M | 15.22M | -196M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
Germany | 34.76M | 173M | 54M | 156M | 48.27M | |||
Total Assets | 175M | 408M | 510M | 696M | 562M | |||
Interest Expense | -566K | -1.04M | -831K | -886K | -946K | |||
Income Tax Expense | - | 4.52M | - | 6.13M | -1.99M | |||
D&A | 5.15M | 6.81M | 7.1M | 12.15M | 12.37M | |||
CAPEX | -5.66M | -6.22M | -30.8M | -16.27M | -6.56M | |||
Net Income | -93.34M | 37.51M | -96.99M | 15.22M | -196M | |||
EBT | -93.34M | 42.04M | -96.99M | 21.35M | -198M | |||
Operating Income | -86.29M | 29.95M | -102M | -38.62M | -182M |
- Stock Market
- Stocks
- IMTX Stock
- Financials Immatics N.V.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
